Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 10/2015

01-10-2015 | Breast Oncology

Oncoplastic Breast-Conserving Surgery Reduces Mastectomy and Postoperative Re-excision Rates

Authors: Angelena Crown, MD, Debra G. Wechter, MD, Janie W. Grumley, MD

Published in: Annals of Surgical Oncology | Issue 10/2015

Login to get access

Abstract

Background

Oncoplastic breast-conserving surgery (BCS) integrates partial mastectomy with plastic surgery techniques to facilitate breast cancer resection with clear surgical margins and preservation of breast cosmesis. In 2011, oncoplastic BCS was adopted as standard surgical treatment for breast cancer patients at Virginia Mason Medical Center, Seattle, WA.

Methods

This single-institution retrospective review evaluates the mastectomy and postoperative re-excision rates before and after adoption of oncoplastic BCS. All patients undergoing surgical treatment of breast cancer were identified from institutional databases for the periods January 2009 through December 2010 [standard surgery group (SS)] and January 2013 through September 2014 [oncoplastic surgery group (OS)].

Results

A total of 812 patients were evaluated; 425 patients were treated in the SS group compared with 387 patients in the OS group. The mastectomy rate in the SS group was 34 % compared with 15 % in the OS group (p < 0.001), and the average tumor size for patients undergoing BCS was 12.7 mm in the SS group compared with 15.4 mm in the OS group (p = 0.04). Despite the larger average tumor size, the postoperative re-excision rate for patients undergoing BCS in the SS group was 32 % as opposed to 18 % in the OS group (p < 0.001).

Conclusions

Oncoplastic BCS significantly reduced the rates of mastectomy and postoperative re-excision in breast cancer patients while treating larger cancers. This study suggests that use of OS techniques can effectively treat larger cancers while maximizing breast cosmesis and minimizing the need to resort to mastectomy.
Literature
1.
Abe O, Abe K, Asaishi K, et al. Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials. N Engl J Med. 1995;333(22):1444–55.CrossRef
2.
Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227–32.CrossRefPubMed
3.
Fisher B, Anderson S, Bryant J. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233–41.CrossRefPubMed
4.
Holmes DR, Schooler W, Smith R. Oncoplastic approaches to breast conservation. Int J Breast Cancer. 2011;2011:1–16.CrossRef
5.
Clough KB, Kaufman GJ, Nos C, Buccimazza I, Sarfati I. Improving breast cancer surgery: a classification and quadrant per quadrant atlas for oncoplastic surgery. Ann Surg Oncol. 2010;17:1375–91.CrossRefPubMed
6.
Silverstein, M. How I do it: oncoplastic breast-conservation surgery. Ann Surg Oncol. 2010;17:242–4.CrossRefPubMed
7.
Anderson SJ, Wapnir JJ, Dignam B. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Projects protocols in node-negative breast cancer. J Clin Oncol. 2009;29:2466–73.CrossRef
8.
Scopa CD, Panagiotis AC, Tsamadas AC, Aletra C. Evaluation of margin status in lumpectomy specimens and residual breast carcinoma. Breast J. 2006;12:150–3.CrossRefPubMed
9.
10.
Morrow M, Hamilton AS, Katz SJ. Why do women get mastectomy? Results from a population-based study. J Clin Oncol. 2007;25:605.
11.
Locker GY, Sainsburgy JR, Cuzick J. Breast surgery in the “Arimidex, Tamoxifen Alone or in Combination” (ATAC) trial: American women are more likely than women from the United Kingdom to undergo mastectomy. Cancer. 2004;101(4):735–40.CrossRefPubMed
12.
Shrotria S. Techniques for improving the cosmetic outcome of breast conserving surgery. Eur J Surg Oncol. 2001;27:109–12.CrossRefPubMed
13.
Santos G, Urban C, Edelweiss MI, et al. Long-term comparison of aesthetical outcomes after oncoplastic surgery and lumpectomy in breast cancer patients. Ann Surg Oncol. 2014. doi:10.​1245/​s10434-014-4301-6.PubMed
14.
Keibert GM, de Haes JC, van de Velde CJ. The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review. J Clin Oncol. 1991;9(6):1059–70.
15.
Waljee JF, Hu ES, Newman LA, Alderman AK. Predictors of breast asymmetry after breast-conserving operation for breast cancer. J Am Coll Surg. 2008;206(2):274–80.CrossRefPubMed
16.
Cochrane RA, Valasiadou P, Wilson ARM, Al-Ghazal SK, Macmillan RD. Cosmesis and satisfaction after breast-conserving therapy correlates with the percentage of breast volume excision. Br J Surg. 2003;90(12):1505–9.CrossRefPubMed
17.
Azu M, Abrahamse P, Katz SJ, Jagsi R, Morrow M. What is an adequate margin for breast conserving surgery? Surgeon attitudes and correlates. Ann Surg Oncol. 2010;17:558–63.PubMedCentralCrossRefPubMed
18.
Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical Oncology and American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol. 2014:32(14):1507–15.CrossRefPubMed
19.
Morrow M. Breast conservation and negative margins: how much is enough? Breast. 2009;18:84–6.CrossRef
20.
Clough KB, Ihrai T, Oden S, et al. Oncoplastic surgery for breast cancer based on tumour location and a quadrant-per-quadrant atlas. Br J Surg. 2012:99(10):1389–95.CrossRefPubMed
21.
Tenofsky PL, Dowell P, Topalovski T, Helmer SD. Surgical, oncologic, and cosmetic differences between oncoplastic and nononcoplastic breast conserving surgery in breast cancer patients. Am J Surg. 2014:207(3):398–402.CrossRefPubMed
Metadata
Title
Oncoplastic Breast-Conserving Surgery Reduces Mastectomy and Postoperative Re-excision Rates
Authors
Angelena Crown, MD
Debra G. Wechter, MD
Janie W. Grumley, MD
Publication date
01-10-2015
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 10/2015
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4738-2

Other articles of this Issue 10/2015

Annals of Surgical Oncology 10/2015 Go to the issue

Breast Oncology

Nipple-Sparing Mastectomy in Irradiated Breasts: Selecting Patients to Minimize Complications

Breast Oncology

Overall Survival, Disease-Free Survival, Local Recurrence, and Nipple–Areolar Recurrence in the Setting of Nipple-Sparing Mastectomy: A Meta-Analysis and Systematic Review

Breast Oncology

Long-Term Psychosocial Functioning in Women with Bilateral Prophylactic Mastectomy: Does Preservation of the Nipple-Areolar Complex Make a Difference?

Breast Oncology

The Ethics of Breast Surgery

Breast Oncology

Chemoprevention for Breast Cancer

Breast Oncology

Negative Genetic Testing Does Not Deter Contralateral Prophylactic Mastectomy in Younger Patients with Greater Family Histories of Breast Cancer